Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$270.54
+1.3%
$267.53
$199.90
▼
$290.25
$680.19B0.227.42 million shs11.92 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,346.40
-0.3%
$1,268.06
$850.51
▼
$1,475.25
$1.35T0.43.05 million shs3.54 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$133.56
+0.6%
$145.28
$95.36
▼
$156.92
$356.13B0.139.56 million shs15.61 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.41
-0.5%
$28.82
$23.62
▼
$31.44
$164.50B0.3136.19 million shs38.28 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$79.09
-2.1%
$77.16
$68.77
▼
$132.49
$34.29B0.674.57 million shs6.10 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.32%-5.33%+5.00%-0.06%+33.24%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.43%-6.76%+5.86%+7.09%+28.36%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.62%-9.60%-10.95%-12.38%+40.35%
Pfizer Inc. stock logo
PFE
Pfizer
-0.55%-5.10%-8.24%-2.10%+9.96%
Zoetis Inc. stock logo
ZTS
Zoetis
-2.17%-5.45%-0.55%+1.76%-32.38%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$270.54
+1.3%
$267.53
$199.90
▼
$290.25
$680.19B0.227.42 million shs11.92 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,346.40
-0.3%
$1,268.06
$850.51
▼
$1,475.25
$1.35T0.43.05 million shs3.54 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$133.56
+0.6%
$145.28
$95.36
▼
$156.92
$356.13B0.139.56 million shs15.61 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.41
-0.5%
$28.82
$23.62
▼
$31.44
$164.50B0.3136.19 million shs38.28 million shs
Zoetis Inc. stock logo
ZTS
Zoetis
$79.09
-2.1%
$77.16
$68.77
▼
$132.49
$34.29B0.674.57 million shs6.10 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.32%-5.33%+5.00%-0.06%+33.24%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.43%-6.76%+5.86%+7.09%+28.36%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.62%-9.60%-10.95%-12.38%+40.35%
Pfizer Inc. stock logo
PFE
Pfizer
-0.55%-5.10%-8.24%-2.10%+9.96%
Zoetis Inc. stock logo
ZTS
Zoetis
-2.17%-5.45%-0.55%+1.76%-32.38%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.73
Moderate Buy$276.542.22% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.83
Moderate Buy$1,422.005.61% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.62
Moderate Buy$155.7416.61% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.18
Hold$30.3210.59% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
2.35
Hold$101.2528.02% Upside

Current Analyst Ratings Breakdown

Latest ZTS, LLY, JNJ, MRK, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetNeutral$285.00 ➝ $300.00
11/17/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,600.00
11/17/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
UpgradeStrong Sell ➝ Hold
11/16/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,400.00 ➝ $1,550.00
11/13/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UpgradeBuy (B) ➝ Buy (B+)
11/12/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingMarket Perform$29.00
11/12/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
DowngradeBuy ➝ Hold
11/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C) ➝ Hold (C+)
11/9/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,610.00 ➝ $1,700.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$33.00 ➝ $34.00
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B6.91$13.52 per share20.01$33.87 per share7.99
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B19.43$23.64 per share56.95$42.81 per share31.45
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$65.01B5.06$10.56 per share12.65$18.23 per share7.33
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.50$4.18 per share6.56$15.67 per share1.75
Zoetis Inc. stock logo
ZTS
Zoetis
$9.47B3.39$7.09 per share11.15$8.13 per share9.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$6.6040.9923.482.7916.20%31.64%13.04%1/26/2027 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$30.8143.7026.421.7131.90%86.76%22.03%2/3/2027 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$18.25B$0.97137.6914.716.623.64%16.73%5.88%2/2/2027 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.7039.169.261.906.34%19.88%8.52%2/2/2027 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.67B$5.8813.4512.461.2226.15%85.90%18.39%N/A

Latest ZTS, LLY, JNJ, MRK, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Zoetis Inc. stock logo
ZTS
Zoetis
$1.51$1.75+$0.24$1.44$2.30 billion$2.39 billion
11/3/2026Q3 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7350$0.87+$0.1350$0.56$15.85 billion$16.58 billion
10/29/2026Q3 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.71$7.48+$1.77$7.22$22.58 billion$24.40 billion
10/29/2026Q3 2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.09$2.49+$0.40$2.04$17.33 billion$18.09 billion
10/13/2026Q3 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.53$2.59+$0.06$0.09$25.38 billion$25.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.361.98%+5.25%81.21%64 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.51%+15.18%22.46%11 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.402.55%+5.75%350.52%14 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.27%-13.20%245.71%16 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.122.68%+20.11%36.05%14 Years

Latest ZTS, LLY, JNJ, MRK, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/17/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.882.46%12/15/202612/15/20261/8/2027
10/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.48%11/13/202611/13/202612/10/2026
10/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.15%11/24/202611/24/202612/8/2026
10/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.435.85%11/6/202611/6/202612/7/2026
10/8/2026
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.532.66%10/30/202610/30/202612/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.44
1.02
0.74
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.17
1.39
1.00
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1.11
1.35
1.14
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.42
1.10
Zoetis Inc. stock logo
ZTS
Zoetis
2.51
2.35
1.40

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.17%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
Zoetis Inc. stock logo
ZTS
Zoetis
0.22%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000940.74 million939.43 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.47 billion2.46 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
14,500406.32 million405.42 millionOptionable

Recent News About These Companies

Why Did Zoetis Stock Move?
Aberdeen Group plc Sells 824,353 Shares of Zoetis Inc. $ZTS
Zoetis wins USDA license for 3-in-1 chicken vaccine
Zoetis stock gets USDA license for three-disease poultry vaccine
Zoetis Receives USDA License for 3-Disease Chicken Vaccine
Zoetis (ZTS) Climbed, So What Is Behind The Latest Attention?
Barclays Remains a Hold on Zoetis (ZTS)
ETFs Are Net Sellers of Zoetis (ZTS) on Monday
Zoetis (NYSE:ZTS) Stock Sale Reported by Rep. Byron Donalds
Zoetis Braces for Weak Vet Visits, Bets on New Products for Growth
Zoetis stock gains USDA license for 75-day itch treatment
Zoetis stock trades 2.69% above Wednesday's Xetra close

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$270.54 +3.40 (+1.27%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$270.75 +0.21 (+0.08%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,346.40 -4.72 (-0.35%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$1,347.00 +0.60 (+0.04%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$133.56 +0.75 (+0.56%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$134.06 +0.50 (+0.38%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$27.41 -0.13 (-0.46%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$27.44 +0.02 (+0.08%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Zoetis stock logo

Zoetis NYSE:ZTS

$79.09 -1.70 (-2.10%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$78.67 -0.42 (-0.53%)
As of 11/20/2026 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.